Probing the Effects of Stress Mediators on the Human Hair Follicle

【摘要】  Stress alters murine hair growth, depending on substance P-mediated neurogenic inflammation and nerve growth factor (NGF), a key modulator of hair growth termination (catagen induction). Whether this is of any relevance in human hair follicles (HFs) is completely unclear. Therefore, we have investigated the effects of substance P, the central cutaneous prototypic stress-associated neuropeptide, on normal, growing human scalp HFs in organ culture. We show that these prominently expressed substance P receptor (NK1) at the gene and protein level. Organ-cultured HFs responded to substance P by premature catagen development, down-regulation of NK1, and up-regulation of neutral endopeptidase (degrades substance P). This was accompanied by mast cell degranulation in the HF connective tissue sheath, indicating neurogenic inflammation. Substance P down-regulated immunoreactivity for the growth-promoting NGF receptor (TrkA), whereas it up-regulated NGF and its apoptosis- and catagen-promoting receptor (p75NTR). In addition, MHC class I and ??2-microglobulin immunoreactivity were up-regulated and detected ectopically, indicating collapse of the HF immune privilege. In conclusion, we present a simplistic, but instructive, organ culture assay to demonstrate sensitivity of the human HF to key skin stress mediators. The data obtained therewith allow one to sketch the first evidence-based biological explanation for how stress may trigger or aggravate telogen effluvium and alopecia areata.
--------------------------------------------------------------------------------
It has been hotly disputed for decades, whether or not stress can exert direct effects on human hair growth, for example in stress-induced telogen effluvium or alopecia areata.1-4 This controversial debate has recently been revived by our finding that a defined perceived stressor-inescapable noise as a model for psychoemotional stress indeed exerts multiple and significant hair growth-inhibitory effects in the mouse.4-12 However, epidemiological and clinical studies, so far, have failed to demonstrate a definite causal link between psychoemotional stressors and hair growth alterations in the human scalp.3
Stress inhibits murine hair follicle (HF) keratinocyte proliferation, prematurely induces intrafollicular keratinocyte apoptosis and HF regression (catagen), and triggers mast cell-dependent neurogenic inflammation.4,5,7,9 This critically depends on substance P, the prototypic stress-associated neuropeptide in skin and neurogenic inflammation.4,5,9,12-16 Substance P operates as a central mediator of intracutaneous neurogenic inflammation,13,17 and increased contacts between substance P-containing nerve fibers and mast cells with subsequent increased mast cell degranulation and cellular infiltration have been observed after stress exposure in mice.4,12
Alongside substance P, nerve growth factor (NGF) has recently been described as a stress-associated growth factor4,18 and is one of the key catagen-inducing factors involved in stress-mediated hair growth inhibition in the mouse.6 This neurotrophin does not only maintain and enhance substance P+ cutaneous innervation, but it also serves as a potent epitheliotrophin in murine and human keratinocytes and receives increasing attention as a promoter of neurogenic inflammation.4,18-21
Premature catagen is a common feature of any damage to the HF.22 Inflammation-associated damage and premature HF regression are frequently accompanied by ectopic up-regulation of major histocompatibility complex (MHC) class I molecules in the HF epithelium, the break down of the so-called HF immune privilege, for example in alopecia areata27-31 or after interferon (IFN)-.32,33 The subsequent lack of protection from autoimmune attack likely plays a key role in disease pathogenesis thus linking stress and HF autoimmunity.23-26
Therefore, to determine whether prototypic stress mediators exert stress effects on human HFs in other than a complex in vivo setting,34,35 we have taken to a simplistic and reductionistic but highly informative ex vivo approach to perform a pilot test on the effects of substance P directly.36,37 Elaborating on this approach, we now have addressed the following specific questions:
• Do human scalp HFs express receptors for the prototypic stress-associated neuropeptide substance P, specifically neurokinin-1 receptors (NK1)?
• Are human HFs responsive to signaling induced by the NK1 ligand, substance P? Specifically, does substance P affect human hair shaft growth, hair matrix keratinocyte proliferation/apoptosis, and HF cycling in vitro?
• Does substance P activate mast cells of the HF connective tissue sheath (as a first indication that this stress mediator can induce neurogenic inflammation within the pilosebaceous unit)?
• Are there any indications that these substance P effects involve the key catagen inducer and prototypic stress-associated growth factor, the neurotrophin NGF?
• Does substance P have any effect on MHC class I-based HF immune privilege?

【关键词】  mediators follicle

Materials and Methods

Tissue and HF Sources

Temporal scalp skin was obtained from disposed excess skin samples derived from healthy patients undergoing elective plastic surgery (face lifting) after obtaining informed consent, following Declaration of Helsinki principles. A total of 20 different donor samples were obtained. After excision, tissue was maintained in Williams?? E medium (Biochrom KG Seromed, Berlin, Germany) for transportation at 4??C for up to 24 hours. On arrival in the laboratory facility, the samples were divided: one part was immediately snap-frozen in liquid nitrogen for immunohistochemistry and RNA extraction, and another part was processed for HF organ culture as described below. Immunohistochemistry was performed on each sample, and culture experiments were performed on at least five donor samples per group if not otherwise indicated in the figure legends.

Human HF Organ Culture

Anagen VI HFs were isolated by microdissection and cultured in Williams?? E medium (Biocrom AG) supplemented with insulin (10 µg/ml; Sigma, Taufkirchen, Germany), hydrocortisone (10 ng/ml) (Sigma), penicillin (Sigma), streptomycin (Sigma), and L-glutamine (2 mmol/L) (Sigma) using 24-well culture plates as published before.36,38,39 Each well contained 500 µl of Williams?? E medium and vehicle as well as test substances, which were added 100 times concentrated in a total volume of 5 µl. Control HFs received only vehicle. Test groups were treated with 10C6, 10C8, and 10C10 mol/L substance P (Sigma) for a period of 3 days starting with day 1 (after dissection). The doses studied were selected because they are routinely used in neuropeptide studies with good effect on mast cells and keratinocytes.40-43,64 Higher concentrations yielded toxic effects in our culture model (not shown).

On days 0, 1, and 3, each well was photodocumented, and the total length of each HF was measured using an inverted microscope fitted with an eyepiece measuring graticule. Follicle length was defined as the distance between the tip of the protruding hair shaft and the base of the HF. Medium was replaced and fresh supplements added on day 1, and HFs were harvested for immunohistochemistry or RNA extraction on day 3 after isolation. To this effect HFs were washed in three rinses of sterile isotonic phosphate-buffered saline (PBS) and either embedded in Histogel embedding medium (Vector Laboratories, Peterborough, UK) or left without embedding medium before rapid snap-freezing in liquid nitrogen as described previously.21 Samples were then stored at C80??C until cryosectioning. For histochemical and immunohistochemical processing, 8-µm-thick longitudinal cryosections through human scalp skin HFs were mounted on glass slides, fixed in ice-cold acetone for 10 minutes, and left for 1 hour to air-dry before staining procedures.

Only organ culture experiments, in which the control HFs showed at least the expected minimal growth activity (ie, 40% hair shaft elongation during the culture period), were included in the current study. HF cultures with substandard HF growth in the control group (ie, 20% or less elongation during the culture period, indicating suboptimal HF preservation during surgery, transport, and/or microdissection) were excluded from analysis.

Hair Cycle Staging

Cultured HFs were staged after 3 days in culture by Ki-67-terminal dUTP nick-end labeling (TUNEL) double assay as described below, following previously published morphological characteristics of the murine and human hair cycle44 adapted for cultured human anagen HFs as described previously.21,45,46 Briefly, HFs were classified as anagen VI, early catagen, mid catagen, or late catagen. For statistical analysis (hair cycle score), HFs in anagen VI were arbitrarily attributed a score of 0, in early catagen a score of 1, in mid catagen of 2, and in late catagen of 3. The sum of scores per group was then divided by the number of investigated HFs. The mean value of these scores is a reliable quantitative indicator of the mean HF stage that has been reached on average by a larger population of HFs after culture.

Routine Histochemistry

Sections prepared as described above were processed for Giemsa (Merck, Darmstadt, Germany) staining for the detection of mast cells in the connective tissue sheath after 3 days in culture as described elsewhere.47 In brief, Giemsa was applied at a 1:10 dilution with 2% sodium borate solution for 45 minutes at room temperature. Differentiation was achieved using 0.02% acetic acid under microscopic control, and slides were dehydrated and mounted. Mast cells were classified as degranulated when eight or more granules could be found outside the cell membrane, as published before.4,5,6,7,9,12,47

Standard Immunofluorescence

Sections prepared as described above were used to detect NGF, TrkA, and Ki-67 expression. After blocking nonspecific binding with 10% normal goat serum (DAKO, Hamburg, Germany) in Tris-buffered saline or PBS, pH 7.4, primary antibodies (Table 1) were applied in PBS with 2% normal goat serum overnight at 4??C. After washing, fluorescein isothiocyanate- or tetramethyl-rhodamine isothiocyante-labeled goat anti-rabbit secondary antibody (1:200; Jackson ImmunoResearch, West Grove, PA) was added for 1 hour at 37??C in PBS with 2% normal goat serum. All sections were counterstained with 4',6-diamidino-2'-phenylindol-dihydrochlorid (DAPI; Boehringer Mannheim, Mannheim, Germany) for identification of cell nuclei. All immunohistochemical staining steps were performed in light-protected humidity chambers and interspersed by washing steps in Tris-buffered saline or PBS, respectively.

Table 1. Antihuman Primary Antibodies

Tyramide-Substrate Amplification (TSA) Immunofluorescence

For the detection of NK1, p75, c-Kit (CD117), and MHC class I molecules (HLA-ABC) (Table 1) in human full thickness skin biopsies and in isolated HFs after 3 days in culture, the TSA method was applied to sections prepared as described above, following the manufacturer??s instructions . Briefly, after blocking of endogenous peroxidase activity, sections were first incubated with the respective primary antibody overnight at room temperature followed by incubation with biotinylated goat anti-rabbit (1:200, Jackson ImmunoResearch) or anti-mouse antibody (1:200; Beckman Coulter, Marseille, France) for 1 hour at 37??C. Finally biotinylated secondary antibodies were labeled with streptavidin-horseradish peroxidase (TSA), and the reaction was amplified by fluorescein or tetramethylrhodamine isothiocyanate-tyramide amplification reagent (TSA) at room temperature. DAPI counterstaining and washing steps were performed as described above.

Ki-67-TUNEL Double Assay

Sections were fixed in 1% paraformaldehyde and postfixed in 2:1 ethanol to acetic acid at C20??C. TUNEL staining was performed as instructed by the manufacturer (ApopTag Plus fluorescein in situ apoptosis detection kit; Chemicon International, Hampshire, UK) and combined with the above-described standard immunofluorescence staining of Ki-67.

Alkaline Phosphatase-Based EnVision Technique for Light Microscopy

For the staining of NK1, MHC class I molecules (HLA-ABC), and ??2-microglobulin, we used the alkaline phosphatase-based EnVision technique developed by DAKO as described before.25,48

Controls for Immunohistochemistry

For negative controls the primary antibody was omitted and the secondary antibody applied without prior primary antibody incubation. For positive controls, well established staining patterns were determined: immunoreactivity in dermal and subcutaneous nerve fiber bundles for NK1, immunoreactivity in subcutaneous nerve fiber bundles for NGF, strong immunoreactivity of the basal layer of the epidermis for TrkA, immunoreactivity in single nerve fibers and small nerve fiber bundles in the subepidermal dermis for p75, immunoreactivity in dermal and subcutaneous mast cells and in epidermal melanocytes for c-Kit, immunoreactivity in all nucleated skin cells except for the proximal anagen hair bulb for MCH class I and ??2-microglobulin, and basal layer epidermal and hair matrix keratinocytes for Ki-67. For TUNEL staining, murine spleen cryosections were used as positive control.

Photodocumentation and Histomorphometry

The sections were examined under an Axiophot microscope with a fluorescence device (Zeiss, Jena, Germany), and photodocumentation was performed with the help of a Hamamatsu digital camera (Hamamatsu Photonics, Hamamatsu, Japan). All histomorphometric analyses were performed on photodocumented staining patterns. Mean fluorescence intensity was measured by the NIH-image system (Sun Microsystems, Santa Clara, CA) in two previously defined reference areas as indicated in the figures. Data were pooled per group, and statistically significant differences from control were determined by the Mann-Whitney U-test for unpaired samples. All results are expressed as means ?? SEM.

Semiquantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Analysis

RNA was extracted using the RNeasy mini kit (Qiagen, Hilden, Germany). Total RNA (0.8 µg) was reverse-transcribed using the First Strand cDNA synthesis kit (Roche, Mannheim, Germany) in an oligo-d(T)15-primed 20-µl reaction. One µl of cDNA was amplified by PCR using the Core PCR kit (Qiagen). The following primers were used: 5'-CTGCTGGATAAACTTCTTCAGGTAG-3' and 5'-AGGACAGTGACGAACTATTTCTGG-3' to amplify NK1 mRNA, 5'-GCAATTCTGTGTTCATCCGTTTG-3' and 5'-ATGTAGCCCAGCCAGTCGAAC-3' to amplify a neutral endopeptidase (NEP) mRNA, 5'-GGCAGTATAATCCAAAGATGGTCAA-3' and 5'-GTCTGGCTTATATCCAACACTTCGT to amplify huHPRT-R, 5'-CCAAGGGAGCAGCTTTCTAT-CC-3' and 5'-GGACATTGCTCTCTGAGTGTGGT-3' to amplify NGF mRNA, 5'-TGGACAACCCTTTCGAGTTCAA-3' and 5'-AGCCACCGAGACCCCAA-3' to amplify TrkA mRNA and 5'-CCTACGGCTACTACCAGGATGAG-3' and 5'-TGGCCTCGTCGGAATACG to amplify p75NTR mRNA. The reactions were cycled for 5 minutes at 94??C, then 30 seconds at 94??C, 1 minute at 58??C, 1 minute at 72??C for 35 cycles, and then 10 minutes at 72??C. For NK1 and NEP, gut RNA served as positive control; for p75, NGF, and TrkA, full-thickness skin served as positive control.

Results

Normal Human Scalp Skin Anagen HFs Express Prominent Immunoreactivity for the Substance P Receptor, NK1

In healthy human scalp skin biopsies, prominent NK1 receptor-like immunoreactivity was found on the epidermal keratinocytes of the stratum granulosum (Figure 1) , whereas expression in the anagen VI HF was localized to the distal, suprainfundibular outer root sheath (ORS), the inner root sheath (most prominently in the proximal HF) (Figure 1) , and the nucleated hair shaft (Figure 1) . With exception of distal ORS keratinocytes, all other NK1+ cell populations were characterized by lack of proliferation and ongoing terminal differentiation, leading to complete keratinization.

Figure 1. Native human scalp skin and native human anagen VI HFs express immunoreactivity for the NK1 receptor. The schematic summaries display the most highly reproducible NK1 immunoreactivity patterns observed in human anagen scalp skin HFs. Cryosections (immunohistochemistry, IHC) from human scalp skin samples containing 80 to 90% anagen HFs were stained with antisera against NK1 (for details see Materials and Methods). All images demonstrate representative immunoreactivity patterns generated with the TSA technique in anagen HFs. Boxes indicate anatomical location of the presented micrographs. Color in schematic drawings and bright red immunolabeling in photomicrographs indicate localization of positive immunoreactivity. Original magnifications, x200.

Weak NK1 immunoreactivity was observed throughout the basal layers of the epidermis, the HF matrix, and the ORS (Figure 1) . These compartments show high proliferation and low differentiation. Outside of epidermis and HF epithelium, strong NK1 immunoreactivity was observed in the sebaceous gland (Figure 1) and nerve fibers (not shown), and somewhat weaker expression was observed in dermal microvascular cells and sweat glands (not shown).

Substance P Inhibits Hair Shaft Elongation and Promotes Development of a Catagen-Like Morphology in Organ-Cultured Human Anagen HFs

As early as 3 days after microdissection, we observed a significant reduction in hair shaft elongation in HFs treated with 10C8 and 10C10 mol/L substance P (Figure 2A) . Reduced hair shaft elongation was accompanied by development of a catagen-like morphology in hair bulbs of HFs treated with various concentrations of substance P, as evidenced by a rounded dermal papilla, a decreased area containing Ki-67+-proliferating keratinocytes in the hair bulb epithelium, and the occurrence of TUNEL+ apoptotic cell nuclei in the HF epithelium (Figure 2B) . This shift toward a catagen-like morphology was significant as evidenced by quantitative hair cycle histomorphometry (Figure 2C) .

Figure 2. Substance P promotes development of a catagen-like hair bulb morphology in cultured human anagen scalp skin HFs. Human anagen scalp skin HFs were cultured for 3 days in the presence of substance P. Hair shaft elongation was measured on days 0 and 3, and HFs were harvested for immunohistochemistry and hair cycle staging on day 3. cts, connective tissue sheath; dp, dermal papilla; hs, hair shaft; irs, inner root sheath; m, matrix; ors, outer root sheath; pu, pigmentary unit. A: Hair shaft elongation is decreased in HFs treated with substance P after 3 days in culture. The effect is dose-dependent, and the differences to control are significant by Mann-Whitney U-test for unpaired samples (**P < 0.01, ***P < 0.001). Each group contains n = 44 to 78 HFs derived from four different donors, which yielded highly reproducible results. B, iCiii: For hair cycle staging, labeling of proliferating cells by Ki-67-immunoreactivity (i) against a background of DAPI+ cell nuclei (ii) and apoptotic cells by TUNEL labeling (iii) was performed. We observed classical morphological changes in the form and size of the dermal papilla in relation to hair bulb and matrix diameter. For example, high numbers of proliferating cells can be observed in a control hair bulb with several layers of proliferating cells in the matrix all around the early catagen-like mildly dilated dermal papilla. No TUNEL+ cells can be detected. In HFs treated with substance P, the HF epithelium containing proliferating cell nuclei is decreased in area and less Ki-67+ cells can be detected around the rounded up mid catagen-like dermal papilla. Note the TUNEL+ cells within the HF epithelium (arrows) and in the connective tissue sheath. C: Statistical analysis of control versus HFs treated with 10C8, 10C10, or 10C12 mol/L substance P for 3 days shows an increase in hair cycle score, assessed as described in Materials and Methods, in substance P-treated HFs indicating a high number of anagen VI HFs in the control group and a high number of late catagen HFs in the substance P groups. The differences to control are significant by Mann-Whitney U-test for unpaired samples (*P < 0.05, ***P < 0.001). Each group contains n = 10 to 23 HFs derived from four different donors, that yielded highly reproducible results. Original magnifications, x200.

Substance P Reduces NK1 Expression in the Hair Bulb and Up-Regulates NEP

After 3 days in culture with various concentrations of substance P, we observed a striking down-regulation of NK1 expression in the HF matrix and ORS (Figure 3A) . This immunohistomorphometric observation was confirmed by decreased levels of NK1 mRNA products (Figure 3B) . Complementarily, the down-regulation of the most prominent cutaneous substance P receptor was accompanied by an up-regulation of the substance P-degrading enzyme NEP, as determined by RT-PCR (Figure 3C) .

Figure 3. NK1 and NEP expression in human hair bulbs is altered after 3 days in culture with substance P. Twenty human anagen scalp skin HFs derived from two different donors were cultured per group for 3 days in the presence of substance P as described in the Materials and Methods section. A, i and ii: Immunohistochemistry of human anagen scalp skin HFs after 3 days in culture against DAPI staining of nuclei (i) reveals persistence of the NK1 expression in the inner root sheath and matrix of a control HF (ii). Treatment with substance P leads to a gradual decrease in NK1 expression with the strongest effect observable after 10C12 mol/L substance P. Please note the individual NK1+ cells that light up in the connective tissue sheath after 10C8 mol/L substance P (arrows). Basement membranes between dermal papilla and HF epithelia are indicated by white dotted lines. B: RT-PCR reveals a strong NK1 expression in the gut and in isolated control HFs. HFs treated with substance P show decreased NK1 expression. C: RT-PCR reveals a weak NEP expression in the gut and in isolated control HFs. HFs treated with substance P show increased NEP expression. Original magnifications, x200.

Substance P Increases Mast Cell Degranulation and Decreases the Total Mast Cell Number in the Connective Tissue Sheath

Human anagen VI scalp skin HFs cultured for 3 days with 10C10 mol/L and 10C12 mol/L substance P showed increased numbers of degranulated mast cells in their connective tissue sheath close to the ORS (not shown). In HFs treated with 10C10 mol/L, virtually all histochemically detectable mast cells were degranulated as evidenced by Giemsa staining (Figure 4A) and histomorphometric analysis (Figure 4B) . Interestingly, after treatment with the highest concentration of substance P, 10C8 mol/L, no mast cells were detectable by Giemsa labeling (not shown), which only labels mast cells if granules are present.

Figure 4. Human connective tissue sheath mast cells in culture respond to substance P treatment by degranulation and maturation in situ. Thirty human anagen scalp skin HFs derived from three different donors (Giemsa) and 18 human anagen scalp skin HFs derived from two different donors (c-Kit) were cultured per group for 3 days in the presence of substance P as described in the Materials and Methods section. A: HFs were labeled by Giemsa staining. On the left two examples of connective tissue mast cells in control HFs are shown. Arrows point at densely stained, compact mast cells. No individual mast cell granules can be distinguished within or detected outside the cell membrane. On the right two examples of degranulated mast cells in HFs treated with an intermediate concentration of substance P (10C10 mol/L) are shown. Arrowheads point to enlarged cells with sparse granulation. Metachromatic mast cell granules can clearly be distinguished, whereas the cell membrane containing them is hard to identify. B: Statistical analysis of control versus HFs treated with 10C10 mol/L substance P for 3 days shows a low percentage of degranulated mast cells in the connective tissue sheath of control HFs as compared to 100% degranulated mast cells as defined in the Materials and Materials section in HFs treated with 10C10 mol/L substance P. The differences to control are significant by Mann Whitney U-test for unpaired samples (**P < 0.01). C: c-Kit immunoreactivity labels primarily melanocytes in the pigmentary unit (pu), blood vessels in the dermal papilla (dp), and mature as well as immature connective tissue sheath (cts) mast cells (arrowheads). Expression in all compartments is here shown to be high in a control HF. Three days of treatment with 10C8 mol/L substance P dramatically decreases the number of c-Kit+ mast cells in the connective tissue sheath but also the c-Kit expression in the pigmentary unit and in blood vessel endothelia. The same effect is present, although less pronounced, after treatment with 10C10 mol/L and 10C12 mol/L substance P. D: Statistical analysis of control versus HFs treated with 10C8, 10C10, or 10C12 mol/L substance P for 3 days shows a high number of c-Kit immunoreactive mast cells in the connective tissue sheath of control HFs as compared to substance P-treated HFs. The effect is dose-dependent, and the differences to control are significant by Mann-Whitney U-test for unpaired samples (**P < 0.01). Original magnifications: x560 (A); x200 (C).

To determine whether mast cells were still present in the connective tissue sheath of HFs treated with 10C8 mol/L substance P, we performed c-Kit staining to determine total mast cell numbers (Figure 4C) . This staining labels both mature, granulated mast cells and immature, ungranulated mast cells alike, all of which express c-Kit on their cell surface.49-51 We observed a dose-dependent effect of substance P on c-Kit+ connective tissue mast cell numbers. The strongest decrease was observed after 10C8 mol/L substance P, but there was still a significantly lower number of c-Kit+ CTS mast cells after stimulation with 10C12 mol/L substance P (Figure 4D) .

Substance P Up-Regulates Intrafollicular NGF and p75NTR Protein Expression and Down-Regulates TrkA Immunoreactivity

Furthermore, treatment of cultured human anagen HFs with substance P up-regulated intrafollicular immunoreactivity for NGF (Figure 5, A and D) , the catagen-promoting neurotrophin,21 which is also appreciated as the prototypic neurotrophin up-regulated during systemic responses to perceived stress.6 At the same time, the low-affinity pan-neurotrophin receptor p75, which plays a central role in NGF-driven apoptosis promotion and HF regression,20,52 was up-regulated in the proximal ORS. Additional weak staining became visible in the proximal HF matrix after substance P treatment (Figure 5, B and D) (the same phenomenon is characteristically observed after catagen induction.20,52 In contrast, immunoreactivity for the high affinity, growth- and survival-promoting NGF receptor (TrkA)20,52 virtually disappeared from the ORS of HFs treated with 10C8 and 10C10 mol/L substance P and was greatly diminished in HF treated with 10C12 mol/L substance P (Figure 5, C and D) . Data obtained by quantitative RT-PCR revealed a decrease in both p75NTR and NGF transcription, whereas TrkA was below detection limit at the time of catagen-induction.

Figure 5. Substance P alters immunoreactivity for NGF and its receptors (TrkA, p75NTR) in organ-cultured human hair bulbs. Twenty-one human anagen scalp skin HFs derived from three different donors were cultured per group for 3 days in the presence of substance P as described in the Materials and Methods section. Basement membranes between dermal papilla and HF epithelia are indicated by white dotted lines. A: NGF expression in a control hair bulb is present throughout the HF epithelium. In HFs treated with substance P this expression is enhanced, and additional weak expression can be observed in the dermal papilla. Note the nuclear pronunciation of the staining pattern. B: p75 pan-neurotrophin receptor expression is present in the ORS as well as the connective tissue sheath (dotted arrow) of a control HF. After treatment with substance P, the expression of p75 is greatly enhanced in the ORS and connective tissue sheath (dotted arrows), and additional weak staining can be observed in the proximal matrix (arrows) and individual cells of the ORS (arrowheads). C: Expression of the high-affinity NGF receptor TrkA locates to the ORS in a control HF. After substance P treatment this expression is virtually absent and only a weak expression can be detected in a HF treated with 10C12 mol/L substance P. D: The mean fluorescence intensity was measured at two previously defined reference areas as indicated in ACC. The observed effects are dose-dependent, and the differences to controls are significant by Mann-Whitney U-test for unpaired samples (*P < 0.05). E: NGF, p75NTR, and TrkA mRNA levels in cultured human HFs after 3 days of culture with or without SP. TaqMan RT-PCR data pooled from three different donors donating 3 to 12 HFs each are displayed Each extraction, containing three HFs, was measured in duplicate, and produced highly reproductive results. Amount of mRNA is presented in percentage of control levels, when control levels equal 100. Original magnifications, x200.

Substance P Up-Regulates Expression of MHC Class I and Associated Molecules and Induces Ectopic MHC Class I Expression in the Anagen Hair Bulb

Using two highly sensitive MHC class Ia immunostaining methods established for light (EnVision) and fluorescence (TSA) microscopy,25 virtually no trace of MHC class I molecule immunoreactivity was found in the matrix, inner root sheath, and proximal ORS of vehicle-treated, organ-cultured human anagen VI HFs (Figure 6A) , whereas MHC class I was expressed within the fibroblastic compartments (the dermal papilla and connective tissue sheath) (Figure 6A) , as expected from our previous studies.25,53

Figure 6. Substance P treatment causes up-regulation and ectopic expression of MHC class I molecules and ??2 microglobulin in cultured human anagen VI HFs. Thirty human anagen scalp skin HFs derived from three different donors were cultured per group for 3 days in the presence of substance P as described in the Materials and Methods section. cts, connective tissue sheath; dp, dermal papilla; hs, hair shaft; irs, inner root sheath; m, matrix; ors, outer root sheath; pu, pigmentary unit; bv, blood vessel. A: Using EnVision and TSA technique weak MHC class I staining can be observed in the dermal papilla and connective tissue sheath of a control HF, whereas the HF epithelium is virtually free of immunoreactivity. HFs treated with 10C8, 10C10, or 10C12 mol/L substance P, as described in Materials and Methods, show increased MHC class I immunoreactivity in the fibroblastic compartments and additional immunoreactivity in the HF matrix generated with EnVision technique. Note the prominently stained connective tissue sheath blood vessels that are easily distinguishable in the sections stained with the TSA technique. This staining technique gives a more precise staining result but less anatomical detail. Reference areas used for determination of mean fluorescence intensity as shown in B are shown exemplary in a HF treated with 10C8 mol/L substance P. Basement membranes between dermal papilla and HF epithelia are indicated by white dotted lines. B: The mean fluorescence intensity was measured at two previously defined reference areas in the matrix and dermal papilla, respectively, as indicated in A (number of investigated HFs per group = 20). The effect is dose-dependent, and the differences to controls are significant by Mann-Whitney U-test for unpaired samples (*P < 0.05). C: ??2 Microglobulin is low in a control HF and mainly labels the connective tissue sheath and dermal papilla. In substance P-treated HFs, an up-regulation of ??2-microglobulin can be observed in dermal papilla and connective tissue sheath, whereas ectopic induction occurs in the proximal HF epithelium, especially in the HF matrix. Original magnifications, x200.

In contrast, we observed an up-regulation of MHC class I expression in the connective tissue sheath and the dermal papilla of organ-cultured anagen scalp skin HFs by 10C8, 10C10, and 10C12 mol/L substance P (Figure 6A) . More importantly, there was also aberrant, ectopic MHC class I immunoreactivity in hair matrix keratinocytes (Figure 6A) , and in some cases in the inner root sheath and ORS of the HF (not shown). After substance P treatment, NIH image analysis revealed that the up-regulation of MHC class I expression in the dermal papilla and HF matrix was significant in all three treatment groups (Figure 6B) . The effect was strongest in HF keratinocytes of follicles treated with 10C8 mol/L substance P and appeared to be dose-dependent (Figure 6B) .

As independent confirmation of these results, ??2-microglobulin expression was seen to mirror the follicular expression of MHC class Ia: ??2-microglobulin immunoreactivity was very low to absent in matrix keratinocytes and weakly present in the dermal papilla and the connective tissue sheath of control HFs (Figure 6C) , whereas treatment with substance P strongly up-regulated ??2-microglobulin in the connective tissue sheath (Figure 6C) . In addition, aberrant ??2-microglobulin expression became detectable in the HF matrix with the strongest up-regulation and additional expression in the ORS after 10C8 mol/L substance P (Figure 6C) .

Discussion

In this instructive and clinically relevant organ culture assay for exploring the direct effects of stress mediators on a complex human miniorgan, we demonstrate sensitivity of the human HF to the key stress-associated neuropeptide, substance P. We show expression of cognate receptors (NK1) on the gene and protein level, hair growth inhibition and premature catagen induction by substance P, down-regulation of NK1, and up-regulation of substance P-degrading enzymes in the HF epithelium. Just as for the substance P-dependent stress response previously seen in and around the HFs of mice in vivo,5-7,9,12,31,55 the in vitro response of human HFs to stimulation with this key stress-associated neuropeptide exhibited signs of neurogenic inflammation. In addition, substance P up-regulates the intrafollicular expression of NGF and its apoptosis- and catagen-promoting receptor p75NTR, whereas the hair growth-promoting NGF receptor TrkA is down-regulated. Finally, and perhaps most importantly, substance P up-regulates (ectopic) MHC class I and ??2-microglobulin expression, suggestive for a stress-associated collapse of the MHC class I-based HF immune privilege.

These data allow one to sketch four plausible hypothetical avenues along which psychoemotional stress via substance P may inhibit human hair growth: 1) down-regulation of proproliferative substance P-signaling in HF keratinocytes; 2) deleterious neurogenic inflammation induced by substance P activation of perifollicular mast cells; 3) activation of catagen-inductive growth factor cascades; and 4) enhanced immune attack on the no-longer-immune-privileged HF epithelium. This offers the first evidence-based biological explanations for how stress may trigger or aggravate telogen effluvium and alopecia areata in human individuals (Figure 7) .

Figure 7. Hypothetical scenario: human hair growth inhibition by substance P. Hypothetical scenario depicting direct and indirect pathways by which substance P may inhibit human hair growth in the context of psychoemotional stress and neurogenic inflammation. On the left an anagen VI hair bulb is depicted. Gray cells with black membrane show location of proliferating Ki-67+ cells in the hair matrix that also express weak NK1 and TrkA immunoreactivity. On the right a regressing (mid catagen) hair bulb is depicted. Light gray cells indicate rarified proliferating Ki-67+ cells that also express NGF and some of which express p75NTR and show ectopic MHC I expression (gray cells with black membrane). Close by a nerve fiber in contact with degranulated mast cells and some monocytes are shown. Note that NK1, TrkA, p75NTR, and MHCII immunoreactivity outside the proliferative compartment are not schematized for easier comprehensibility. MKC, matrix keratinocyte.

The current focus on substance P was not only motivated by the central role that we had previously identified for this neuropeptide in murine stress-induced hair growth inhibition (see above) but also by the implication of substance P in stress-sensitive clinical conditions, in which psychoemotional stress is thought to trigger hair loss.3,27,28,31,54 Moreover, human keratinocytes and scalp HFs express NK1 receptors.56 In culture, substance P stimulates proliferation of keratinocytes57 and organ-cultured murine epidermis.58

That substance P inhibited hair matrix keratinocyte proliferation in our assay, rather than stimulating it, underscores the very distinct, often underestimated, regulatory controls of HF versus epidermal keratinocytes.59-61 Moreover, the growth-promoting effects of substance P on keratinocytes are concentration-dependent and may rely on the presence of additional growth modulators in the culture medium.62,63 In an in situ context, ie, in a physiological epithelial-mesenchymal interaction milieu containing degranulating dermal mast cells, inhibition of keratinocyte proliferation has been shown before at concentrations used in our study.42,55,64 Low levels of cortisol as observed under chronic stress or chronic inflammation may feed into SP skin signaling because it enhances SP production by keratinocytes.14 Also, substance P reportedly induces selective tumor necrosis factor- release by mast cells,65 a cytokine recognized for its keratinocyte-apoptotic and hair growth-inhibitory effects.66-68

The observed down-regulation of NK1 within the HF epithelium and the up-regulation of intrafollicular NEP immunoreactivity after substance P administration (Figure 3) , both of which may reduce the sensitivity of the HF epithelium to direct substance P-induced HF effects,69 further support the hypothesis that indirect mast cell-mediated effects of substance P release play an important part at least in stress-associated hair growth inhibition.

The observed decline in the number of both more and less differentiated mast cells suggests two mechanisms by which mast cells may contribute to deleterious substance P HF effects: substance P activates CTS mast cells, thereby causing a degranulation-induced decline in the number of histochemically detectable mast cells, and changes in growth factor availability and cytokine expression, as commonly observed during inflammation and catagen-like development, here by substance P, may lead to mast cell apoptosis. Mast cell apoptosis seems to be a common mechanism in inflamed tissue to terminate the acute inflammatory response and prevent perpetuation and potential chronification.70,71 Decreased c-Kit ligand stem cell factor,72 increased tumor growth factor-??1,73 and up-regulated IFN-,24 all of which can induce mast cell apoptosis,71,74,75 may play a role in this process. However, possibly because of the very low number of apoptotic events in the mast cell compartment, this escaped detection with the TUNEL methodology used here (data not shown).

It is important to note here that our previous findings in the murine system suggest that substance P effects on the HF are strictly hair cycle-dependent: substance P inhibits late anagen HF growth in vivo9,31,55 but stimulates the growth of resting (telogen) HFs in vivo76 and of early anagen HFs in vitro.43 Because human early anagen HFs cannot easily be microdissected and studied in organ culture, it is as yet unknown whether a similar Janus-faced effect of substance P holds true for human HF biology.

In addition, substance P may inhibit human hair growth indirectly also by down-regulating TrkA expression and by up-regulating both p75NTR and NGF expression in the epithelium of anagen VI HFs.20,52,77 Like in the murine situation during late anagen-catagen transition, however, high NGF protein levels were accompanied by low NGF mRNA expression.78 This seeming discrepancy may reflect a negative feedback loop installed toward the end of anagen-catagen transition to control the proapoptotic cascade boosted by NGF/p75NTR signaling during the short period of HF regression.

The neurotrophin signaling cascade has long been implicated in the termination of murine hair growth, especially via activation of the p75NTR.52,77,78 Moreover, we have shown that NGF is critically involved in stress-associated hair growth termination in mice4,6 and can terminate human anagen VI hair growth and induce premature catagen entry, using the same organ culture model as used here.21

Furthermore, the up-regulation of intrafollicular NGF expression by substance P demonstrated here must be expected to further aggravate inflammatory events, because NGF promotes, eg, inter- and perifollicular mast cell activation/proliferation.79-83 Experiments in the murine system show that stress-induced premature HF regression depends on NK1 expression and mast cells.7 It is therefore feasible to speculate that altered neurotrophin signaling is a result of neurogenic inflammation rather than of direct substance P-keratinocyte effects, especially because substance P+ nerve fibers appear close to HFs only after NGF expression has increased during cycling.84 However, cell culture experiments demonstrate induction of NGF by substance P, whereas a direct effect on receptor expression remains to be shown.85,86

Most strikingly, the up-regulation of MHC class 1 and ??2-microglobulin expression after substance P treatment indicates that substance P is capable of triggering a collapse of MHC class I-based immune privilege of human anagen HFs. This may destroy the follicle??s capacity to sequester anagen-associated autoantigens from immune recognition and renders affected HFs substantially more susceptible to autoaggressive inflammatory events in immunogenetically predisposed individuals with autoreactive T cells.23,24,26,87 To the best of our knowledge, substance P is here shown to be the first neuropeptide that can induce ectopic MHC class I expression on a normally immunoprivileged human tissue in situ. This activity places substance P alongside IFN-, which we had also shown to be capable of doing so, both in murine88 and human HFs.25 In this context, it is particularly intriguing to note that substance P can even stimulate IFN- expression in mononuclear cells.32,33 Given that other clinical autoimmune diseases, such as rheumatoid arthritis, multiple sclerosis, and lupus erythematosus, have also long been felt to be aggravated by psychoemotional stress, as has already been demonstrated in corresponding animal models of these diseases,89-91 the current data encourage one to explore now the specific role of stress-associated neuropeptides such as substance P and their linkage to IFN--induced autoaggressive inflammation in stress-induced triggering, progression, or relapse of other autoimmune diseases.

The leads found here with studying substance P complement our recent study with NGF (the key stress-associated growth factor) in this system77,91 and can now be followed up by studying the effects other major stress mediators, such as CRH, ACTH, cortisol (all of which are generated by human scalp HFs37 ), and catecholamines, on a complex, exemplary human in vitro model system for physiologically relevant neuroectodermal-mesodermal interaction.92

Acknowledgements

We thank Dr. Johannes Bruck, Clinica Vita, Berlin, Germany, and Dr. Meyburg, Klinik f?r Kosmetische Chirurgie, Berlin, Germany, our colleagues in plastic surgery, who generously contributed human scalp skin samples; and Maria Daniltchenko for her excellent technical assistance.

【参考文献】
  York J, Nicholson T, Minors P, Duncan DF: Stressful life events and loss of hair among adult women, a case-control study. Psychol Rep 1998, 82:1044-1046

Paus R: Stress, hair growth control and the neuro-endocrine immune connection. Allergo J 2000, :9411-9420

Hadshiew IM, Foitzik K, Arck PC, Paus R: Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol 2004, 123:455-457

Peters EM, Arck PC, Paus R: Hair growth inhibition by psychoemotional stress: a mouse model for neural mechanisms in hair growth control. Exp Dermatol 2006, 15:1-13

Arck PC, Handjiski B, Hagen E, Joachim R, Klapp BF, Paus R: Indications for a ??brain-hair follicle axis (BHA)??: inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P. FASEB J 2001, 15:2536-2538

Peters EM, Handjiski B, Kuhlmei A, Hagen E, Bielas H, Braun A, Klapp BF, Paus R, Arck PC: Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. Am J Pathol 2004, 165:259-271

Arck PC, Handjiski B, Kuhlmei A, Peters EM, Knackstedt M, Peter A, Hunt SP, Klapp BF, Paus R: Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition. J Mol Med 2005, 83:386-396

Paus R, Peters EM, Eichmuller S, Botchkarev VA: Neural mechanisms of hair growth control. J Invest Dermatol Symp Proc 1997, 2:61-68

Arck PC, Handjiski B, Peters EMJ, Peter AS, Hagen E, Fischer A, Klapp BF, Paus R: Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol 2003, 162:803-814

Botchkarev VA: Neurotrophins and their role in pathogenesis of alopecia areata. J Invest Dermatol Symp Proc 2003, 8:195-198

Toyoda M, Morohashi M: New aspects in acne inflammation. Dermatology 2003, 206:17-23

Peters EM, Kuhlmei A, Tobin DJ, Muller-Rover S, Klapp BF, Arck PC: Stress exposure modulates peptidergic innervation and degranulates mast cells in murine skin. Brain Behav Immun 2005, 19:252-262

Singh LK, Pang X, Alexacos N, Letourneau R, Theoharides TC: Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: a link to neurogenic skin disorders. Brain Behav Immun 1999, 13:225-239

Katayama I, Bae SJ, Hamasaki Y, Igawa K, Miyazaki Y, Yokozeki H, Nishioka K: Stress response, tachykinin, and cutaneous inflammation. J Invest Dermatol Symp Proc 2001, 6:81-86

Black PH: Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun 2002, 16:622-653

Kimata H: Enhancement of allergic skin wheal responses and in vitro allergen-specific IgE production by computer-induced stress in patients with atopic dermatitis. Brain Behav Immun 2003, 17:134-138

Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC: Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 1998, 7:81-96

Lang UE, Anders D, Danker-Hopfe H, Hellweg R: Measurement of nerve growth factor serum concentration in a psychologically stressful situation in men. Stress 2004, 7:39-42

Alleva E, Santucci D: Psychosocial versus "physical" stress situations in rodents and humans: role of neurotrophins. Physiol Behav 2001, 73:313-320

Botchkarev VA, Yaar M, Peters EM, Raychaudhuri SP, Botchkareva NV, Marconi A, Raychaudhuri SK, Paus R, Pincelli C: Neurotrophins in skin biology and pathology. J Invest Dermatol 2006, 126:1719-1727

Peters EM, Stieglitz MG, Liezman C, Overall RW, Nakamura M, Hagen E, Klapp BF, Arck P, Paus R: p75 neurotrophin receptor-mediated signaling promotes human hair follicle regression (catagen). Am J Pathol 2006, 168:221-234

Hendrix S, Handjiski B, Peters EM, Paus R: A guide to assessing damage response pathways of the hair follicle: lessons from cyclophosphamide-induced alopecia in mice. J Invest Dermatol 2005, 125:42-51

Paus R, Slominski A, Czarnetzki BM: Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med 1993, 66:541-554

Paus R, Ito N, Takigawa M, Ito T: The hair follicle and immune privilege. J Invest Dermatol Symp Proc 2003, 8:188-194

Ito T, Ito N, Bettermann A, Tokura Y, Takigawa M, Paus R: Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 2004, 164:623-634

Gilhar A, Kalish RS: Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 2006, 5:64-69

Hordinsky MK, Kennedy W, Wendelschafer-Crabb G, Lewis S: Structure and function of cutaneous nerves in alopecia areata. J Invest Dermatol 1995, 104:28S-29S

Hordinsky MK, Ericson ME: Relationship between follicular nerve supply and alopecia. Dermatol Clin 1996, 14:651-660

Hordinsky MK: Alopecia areatia: pathophysiology and latest developments. J Cutan Med Surg 1999, 3:S28-S30

Hordinsky M, Ericson M: Nerves, neuropeptides, and the human anagen hair follicle. J Deut Dermatol Gesell 2004, 6:506

Siebenhaar F, Sharov AA, Peters EMJ, Sharova TY, Syska W, Mardariev A, Freyschmidt-Paul P, Sundberg J, Maurer M, Botchkarev VA: Substance P as immunomodulatory neuropeptide in a mouse model autoimmune hair loss (alopecia areata). J Invest Dermatol 2007, 127:1489-1497

Levite M: Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc Natl Acad Sci USA 1998, 95:12544-12549

Kang H, Byun DG, Kim JW: Effects of substance P and vasoactive intestinal peptide on interferon-gamma and interleukin-4 production in severe atopic dermatitis. Ann Allergy Asthma Immunol 2000, 85:227-232

Buske-Kirschbaum A, Gierens A, Hollig H, Hellhammer DH: Stress-induced immunomodulation is altered in patients with atopic dermatitis. J Neuroimmunol 2002, 129:161-167

Buske-Kirschbaum A, Kern S, Ebrecht M, Hellhammer DH: Altered distribution of leukocyte subsets and cytokine production in response to acute psychosocial stress in patients with psoriasis vulgaris. Brain Behav Immun 2007, 21:92-99

Philpott M: In vitro maintenance of isolated hair follicles: current status and future development. Exp Dermatol 1999, 8:317-319

Ito N, Ito T, Paus R: The human hair follicle has established a fully functional peripheral equivalent of the hypothamalic-pituitary-adrenal-axis (HPA). Exp Dermatol 2005, 14:158

Philpott MP, Westgate GE, Kealey T: An in vitro model for the study of human hair growth. Ann NY Acad Sci 1991, 642:148-164

Philpott MP, Sanders D, Westgate GE, Kealey T: Human hair growth in vitro: a model for the study of hair follicle biology. J Dermatol Sci 1994, 7:S55-S72

Haegerstrand A, Jonzon B, Dalsgaard CJ, Nilsson J: Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes. Proc Natl Acad Sci USA 1989, 86:5993-5996

Takahashi K, Nakanishi S, Imamura S: Direct effects of cutaneous neuropeptides on adenylyl cyclase activity and proliferation in a keratinocyte cell line: stimulation of cyclic AMP formation by CGRP and VIP/PHM, and inhibition by NPY through G protein-coupled receptors. J Invest Dermatol 1993, 101:646-651

Paus R, Heinzelmann T, Robicsek S, Czarnetzki BM, Maurer M: Substance P stimulates murine epidermal keratinocyte proliferation and dermal mast cell degranulation in situ. Arch Dermatol Res 1995, 287:500-502

Peters EM, Botchkarev VA, Botchkareva NV, Tobin DJ, Paus R: Hair-cycle-associated remodeling of the peptidergic innervation of murine skin, and hair growth modulation by neuropeptides. J Invest Dermatol 2001, 116:236-245

M?ller-Röver S, Handjiski B, van der Veen C, Eichm?ller S, Foitzik K, McKay IA, Stenn KS, Paus R: A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol 2001, 117:3-15

Peters EM, Hansen MG, Overall RW, Nakamura M, Pertile P, Klapp BF, Arck PC, Paus R: Control of human hair growth by neurotrophins: brain-derived neurotrophic factor inhibits hair shaft elongation, induces catagen, and stimulates follicular transforming growth factor beta2 expression. J Invest Dermatol 2005, 124:675-685

Foitzik K, Krause K, Conrad F, Nakamura M, Funk W, Paus R: Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression. Am J Pathol 2006, 168:748-756

Maurer M, Paus R, Czarnetzki BM: Mast cells as modulators of hair follicle cycling. Exp Dermatol 1995, 4:266-271

Ito T, Ito N, Saathoff M, Bettermann A, Takigawa M, Paus R: Interferon- gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles. Br J Dermatol 2005, 152:623-631

Botchkareva NV, Khlgatian M, Longley BJ, Botchkarev VA, Gilchrest BA: SCF/c-kit signaling is required for cyclic regeneration of the hair pigmentation unit. FASEB J 2001, 15:645-658

Peters EM, Tobin DJ, Botchkareva N, Maurer M, Paus R: Migration of melanoblasts into the developing murine hair follicle is accompanied by transient c-Kit expression. J Histochem Cytochem 2002, 50:751-766

Gurish MF, Boyce JA: Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell. J Allergy Clin Immunol 2006, 117:1285-1291

Botchkarev VA, Botchkareva NV, Peters EM, Paus R: Epithelial growth control by neurotrophins: leads and lessons from the hair follicle. Prog Brain Res 2004, 146:493-513

Christoph T, Muller-Rover S, Audring H, Tobin DJ, Hermes B, Cotsarelis G, Ruckert R, Paus R: The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol 2000, 142:862-873

Gupta MA, Gupta AK, Watteel GN: Stress and alopecia areata: a psychodermatologic study. Acta Derm Venereol 1997, 77:296-298

Maurer M, Fischer E, Handjiski B, von Stebut E, Algermissen B, Bavandi A, Paus R: Activated skin mast cells are involved in murine hair follicle regression (catagen). Lab Invest 1997, 77:319-332

Liu JY, Hu JH, Zhu QG, Li FQ, Sun HJ: Substance P receptor expression in human skin keratinocytes and fibroblasts. Br J Dermatol 2006, 155:657-662

Tanaka T, Danno K, Ikai K, Imamura S: Effects of substance P and substance K on the growth of cultured keratinocytes. J Invest Dermatol 1988, 90:399-401

Paus R, Heinzelmann T, Robicsek S, Czarnetzki BM, Maurer M: Substance P stimulates murine epidermal keratinocyte proliferation and dermal mast cell degranulation in situ. Arch Dermatol Res 1995, 287:500-502

Botchkarev VA, Metz M, Botchkareva NV, Welker P, Lommatzsch M, Renz H, Paus R: Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 act as "epitheliotrophins" in murine skin. Lab Invest 1999, 79:557-572

Stenn KS, Paus R: Controls of hair follicle cycling. Physiol Rev 2001, 81:449-494

Paus R, Foitzik K: In search of the "hair cycle clock": a guided tour. Differentiation 2004, 72:489-511

Pincelli C, Fantini F, Romualdi P, Sevignani C, Lesa G, Benassi L, Giannetti A: Substance P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured human keratinocytes. J Invest Dermatol 1992, 98:421-427

McGovern UB, Jones KT, Sharpe GR: Intracellular calcium as a second messenger following growth stimulation of human keratinocytes. Br J Dermatol 1995, 132:892-896

Kozakiewicz M, Godlewski A: Modulation of the mitotic activity and population of the mast cells in the oral mucosa by substance P. Cell Mol Biol Lett 2003, 8:727-734

Ansel JC, Brown JR, Payan DG, Brown MA: Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 1993, 150:4478-4485

Hoffmann R, Eicheler W, Huth A, Wenzel E, Happle R: Cytokines and growth factors influence hair growth in vitro. Possible implications for the pathogenesis and treatment of alopecia areata. Arch Dermatol Res 1996, 288:153-156

Blasing H, Hendrix S, Paus R: Pro-inflammatory cytokines upregulate the skin immunoreactivity for NGF. NT-3, NT-4 and their receptor, p75NTR in vivo: a preliminary report. Arch Dermatol Res 2005, 296:580-584

Tong X, Coulombe PA: Keratin 17 modulates hair follicle cycling in a TNFalpha-dependent fashion. Genes Dev 2006, 20:1353-1364

Scholzen TE, Luger TA: Neutral endopeptidase and angiotensin-converting enzyme??key enzymes terminating the action of neuroendocrine mediators. Exp Dermatol 2004, 4:22-26

Gurish MF, Boyce JA: Mast cell growth, differentiation, and death. Clin Rev Allergy Immunol 2002, 22:107-118

Norozian F, Kashyap M, Ramirez CD, Patel N, Kepley CL, Barnstein BO, Ryan JJ: TGFbeta1 induces mast cell apoptosis. Exp Hematol 2006, 34:579-587

Peters EM, Maurer M, Botchkarev VA, Jensen K, Welker P, Scott GA, Paus R: Kit is expressed by epithelial cells in vivo. J Invest Dermatol 2003, 121:976-984

Foitzik K, Lindner G, Mueller-Roever S, Maurer M, Botchkareva N, Botchkarev V, Handjiski B, Metz M, Hibino T, Soma T, Dotto GP, Paus R: Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J 2000, 14:752-760

Maurer M, Galli SJ: Lack of significant skin inflammation during elimination by apoptosis of large numbers of mouse cutaneous mast cells after cessation of treatment with stem cell factor. Lab Invest 2004, 84:1593-1602

Mann-Chandler MN, Kashyap M, Wright HV, Norozian F, Barnstein BO, Gingras S, Parganas E, Ryan JJ: IFN-gamma induces apoptosis in developing mast cells. J Immunol 2005, 175:3000-3005

Paus R, Heinzelmann T, Schultz KD, Furkert J, Fechner K, Czarnetzki BM: Hair growth induction by substance P. Lab Invest 1994, 71:134-140

Botchkarev VA, Botchkareva NV, Albers KM, Chen LH, Welker P, Paus R: A role for p75 neurotrophin receptor in the control of apoptosis-driven hair follicle regression. FASEB J 2000, 14:1931-1942

Peters EM, Hendrix S, Golz G, Klapp BF, Arck PC, Paus R: Nerve growth factor and its precursor differentially regulate hair cycle progression in mice. J Histochem Cytochem 2005, 11:11

Tal M, Liberman R: Local injection of nerve growth factor (NGF) triggers degranulation of mast cells in rat paw. Neurosci Lett 1997, 221:129-132

Welker P, Grabbe J, Grutzkau A, Henz BM: Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology 1998, 94:310-317

Stempelj M, Ferjan I: Signaling pathway in nerve growth factor induced histamine release from rat mast cells. Inflamm Res 2005, 54:344-349

Tometten M, Klapp BF, Joachim R, Fest S, Zenclussen AC, Peters EM, Hertwig K, Arck PC: Nerve growth factor and its functional receptor TrkA are up-regulated in murine decidual tissue of stress-triggered and substance P-mediated abortion. Am J Reprod Immunol 2004, 51:86-93

Arck PC, Slominski A, Theoharides TC, Peters EM, Paus R: Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 2006, 126:1697-1704

Paus R, Nickoloff BJ, Ito T: A ??hairy?? privilege. Trends Immunol 2005, 26:32-40

R?ckert R, Lindner G, Bulfone-Paus S, Paus R: High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo. Br J Dermatol 2000, 143:1036-1039

Sternberg EM: Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol 2001, 169:429-435

Elenkov IJ, Chrousos GP: Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann NY Acad Sci 2002, 966:290-303

Frieri M: Neuroimmunology and inflammation: implications for therapy of allergic and autoimmune diseases. Ann Allergy Asthma Immunol 2003, 90:34-40

Paus R, Theoharides TC, Arck PC: Neuroimmunoendocrine circuitry of the ??brain-skin connection??. Trends Immunol 2006, 27:32-39

Burbach GJ, Kim KH, Zivony AS, Kim A, Aranda J, Wright S, Naik SM, Caughman SW, Ansel JC, Armstrong CA: The neurosensory tachykinins substance P and neurokinin A directly induce keratinocyte nerve growth factor. J Invest Dermatol 2001, 117:1075-1082

Dallos A, Kiss M, Polyanka H, Dobozy A, Kemeny L, Husz S: Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes. Neuropeptides 2006, 40:251-263

Zhou Z, Kawana S, Aoki E, Katayama M, Nagano M, Suzuki H: Dynamic changes in nerve growth factor and substance P in the murine hair cycle induced by depilation. J Dermatol 2006, 33:833-841

作者单位：Eva M.J. Peters*, Sofia Liotiri, Enik Bod?, Evelin Hagen, Tam?s B?r?, Petra C. Arck and Ralf PausFrom Charit? Center 12,* Internal Medicine and Dermatology, Psycho-Neuro-Immunology, Neuroscience Research Center, University Medicine Charit?, Berlin, Germany; the Department of Dermatology, University